Macquarie Group LTD Atara Biotherapeutics, Inc. Put Options Transaction History
Macquarie Group LTD
- $90.3 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ATRA
# of Institutions
7Shares Held
2.89MCall Options Held
0Put Options Held
0-
Kpcb Xv Associates, LLC1.88MShares$14.7 Million19.79% of portfolio
-
Antipodean Advisors LLC New York, NY1MShares$7.83 Million8.12% of portfolio
-
Ifp Advisors, Inc4.5KShares$35,2350.0% of portfolio
-
American Portfolios Advisors Holbrook, NY4.5KShares$35,2350.0% of portfolio
-
Wipfli Financial Advisors Llc,3.08KShares$24,1080.0% of portfolio
About Atara Biotherapeutics, Inc.
- Ticker ATRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,362,304
- Market Cap $739M
- Description
- Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...